Rankings
▼
Calendar
TIL
Instil Bio, Inc.
$60M
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$138,000
Gross Profit
$138,000
100.0% margin
Operating Income
-$34M
-24379.7% margin
Net Income
-$38M
-27346.4% margin
EPS (Diluted)
$-5.89
Cash Flow
Operating Cash Flow
-$30M
Free Cash Flow
-$80M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$319M
Total Liabilities
$27M
Stockholders' Equity
$292M
Cash & Equivalents
$242M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$138,000
$0
—
Gross Profit
$138,000
-$20,000
+790.0%
Operating Income
-$34M
-$7M
-410.9%
Net Income
-$38M
-$6M
-484.7%
← FY 2019
All Quarters
Q1 2020 →
TIL FY 2020 Earnings — Instil Bio, Inc. Revenue & Financial Results | Market Cap Arena